The emergence of novel psychoactive substances presents a unique challenge for researchers and policymakers alike. Among these, 2-FDCK has gained prominence as a potent dissociative agent with uncertain pharmacological properties. Initial studies suggest that 2-FDCK may elicit comparable effects to other dissociatives, such as ketamine, but its pre